Clinical Trials Browser

Phase NA × venetoclax × Plasma cell × Clear all

NCT06192979 2026-03-09

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Phase NA Recruiting

Immunoglobulin Light-chain Amyloidosis